2020
DOI: 10.1016/j.jctube.2020.100154
|View full text |Cite
|
Sign up to set email alerts
|

User experience and patient satisfaction with tuberculosis care in low- and middle-income countries: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 50 publications
0
16
0
Order By: Relevance
“…There is literature that shows that patients’ experience of being given no explanation about their disease and not keeping information confidential is associated with loss to follow-up. 36 Another study also found the explanation of illness and appropriate treatment by clinicians to be very important to patients. 37 The literature shows that a clear explanation of the diagnosis and good staff attitudes were among the important attributes determining health-seeking behaviour.…”
Section: Discussionmentioning
confidence: 99%
“…There is literature that shows that patients’ experience of being given no explanation about their disease and not keeping information confidential is associated with loss to follow-up. 36 Another study also found the explanation of illness and appropriate treatment by clinicians to be very important to patients. 37 The literature shows that a clear explanation of the diagnosis and good staff attitudes were among the important attributes determining health-seeking behaviour.…”
Section: Discussionmentioning
confidence: 99%
“…Approximately 51% of the adult TB patients in our study initiated care in the formal and informal private sector where studies in LMICs have shown that such providers often lack knowledge of TB symptoms, and TB diagnostic facilities are frequently unavailable ( Cazabon et al, 2020 , Daniels et al, 2019 , Das et al, 2015 ). This finding is comparable to the report of a combined patients pathway analysis (PPA) from 13 high TB burden countries in Africa and south-East Asia, where about 60% of all TB patients initiated care in the private sector ( Chin and Hanson, 2017 ).…”
Section: Discussionmentioning
confidence: 99%
“…Successful adherence for diseases with a prolonged treatment course, such as MDR-TB, requires a high level of dosing implementation (ie, taking a medication dose on a given day) and persistence (ie, taking medications for the entire duration of therapy [ 3 ]). Factors contributing to nonadherence are complex and include therapy-related (eg, toxicities [ 4 ]), psychosocial (eg, alcohol use [ 5 ], depression [ 6 ], and stigma [ 7 ]), structural (eg, distance from clinics and medication costs [ 8 , 9 ]), and health system–related challenges (eg, poor user experience with the health system). Patients with MDR-TB face particularly high levels of drug toxicity [ 4 ] and psychosocial barriers, including depression, substance use disorders, stigma, and discrimination [ 10 ].…”
Section: Introductionmentioning
confidence: 99%